Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase NA 1Phase 2 1

Status

Completed 61Terminated 11Recruiting 9Unknown 6Active not recruiting 4Approved for marketing 2Withdrawn 1Suspended 1Not yet recruiting 1No longer available 1

Sponsor Class

OTHER 14INDUSTRY 4NIH 3

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 4Sarcoma 1Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 298Neoplasms 179Breast Neoplasms 170Colorectal Neoplasms 107Neoplasm Metastasis 100Melanoma 99Multiple Myeloma 93Prostatic Neoplasms 90Ovarian Neoplasms 83Recurrence 80Carcinoma, Renal Cell 73Lung Neoplasms 71Stomach Neoplasms 67Squamous Cell Carcinoma of Head and Neck 67Lymphoma, Non-Hodgkin 61Pancreatic Neoplasms 59Leukemia, Lymphocytic, Chronic, B-Cell 56Leukemia, Myeloid, Acute 54Carcinoma, Hepatocellular 48Triple Negative Breast Neoplasms 47Small Cell Lung Carcinoma 46Urinary Bladder Neoplasms 45Lymphoma, Large B-Cell, Diffuse 43Head and Neck Neoplasms 41Endometrial Neoplasms 41Lymphoma, Follicular 39Lymphoma 37Uterine Cervical Neoplasms 35Parkinson Disease 4, Autosomal Dominant Lewy Body 34Glioblastoma 34

Interventions

MAPRE1 protein, human 1BO-112 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × INDUSTRY × Carcinoma, Basal Cell × Clear all
NCT04349436 2026-04-22

ARTACUS

Replimune, Inc.

Phase 1/2 Active not recruiting
69 enrolled
Dermatologic

Carcinoma, Carcinoma, Basal Cell, Neoplasms, Skin Neoplasms, Carcinoma, Merkel Cell

NCT03737734 2026-04-06

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

Alpha Tau Medical LTD.

Phase NA Active not recruiting
30 enrolled
DermatologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Lip Neoplasms, Sarcoma, Kaposi, Skin Neoplasms, Soft Tissue Neoplasms, Tongue Neoplasms

NCT06422936 2026-01-26

SPOTLIGHT204

Highlight Therapeutics

Phase 2 Active not recruiting
60 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT04928222 2023-04-14

Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II)

SkinJect, Inc.

Phase 1/2 Active not recruiting
25 enrolled
Dermatologic

Carcinoma, Basal Cell, Neoplasms, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡